Charles River Laboratories International (CRL) Net Income towards Common Stockholders (QoQ) (2009 - 2026)
Powered by 
Analysis
Charles River Laboratories International (CRL) Net Income towards Common Stockholders (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 94.87% |
| Mar 28, 2026 | 94.65% |
| Dec 27, 2025 | -608.17% |
| Sep 27, 2025 | 4.01% |
| Jun 28, 2025 | 105.45% |
| Mar 29, 2025 | 111.81% |
| Dec 28, 2024 | -414.07% |
| Sep 28, 2024 | -23.68% |
| Jun 29, 2024 | 33.65% |
| Mar 30, 2024 | -64.01% |
| Dec 30, 2023 | 114.08% |
| Sep 30, 2023 | -9.93% |
| Jul 1, 2023 | -5.93% |
| Apr 1, 2023 | -45.46% |
| Dec 31, 2022 | 93.73% |
| Sep 24, 2022 | -11.79% |
| Jun 25, 2022 | 16.21% |
| Mar 26, 2022 | -31.90% |
| Dec 25, 2021 | 32.97% |
| Sep 25, 2021 | 16.95% |